Company intelligence / Profile preview

Mahima Life Sciences

Ownership: Private
Employees: ~63
Development stage: Commercial

Overview

Mahima Life Sciences is an active commercial manufacturer of APIs (especially corticosteroids, antibiotics, and vitamins) with a strong global presence in over 50 countries. There are no disclosed clinical studies, as the company focuses on bulk APIs rather than end formulations.

Modalities: Small moleculeVitaminAntibiotic
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Mahima Life Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mahima Life Sciences.

Explore the full profile